Literature DB >> 10684275

Infection of primary human monocytes by Epstein-Barr virus.

M Savard1, C Bélanger, M Tardif, P Gourde, L Flamand, J Gosselin.   

Abstract

Previous studies have reported that infection of monocytes by viruses such as cytomegalovirus and human immunodeficiency virus weakens host natural immunity. In the present study, we demonstrated the capability of Epstein-Barr virus (EBV) to infect and replicate in freshly isolated human monocytes. Using electron microscopy analysis, we observed the presence of EBV virions in the cytoplasm and nuclei of approximately 20% of monocytes. This was confirmed by Southern blot analysis of EBV genomic DNA sequences in isolated nuclei from monocytes. Infection of monocytes by EBV leads to the activation of the replicative cycle. This was supported by the detection of immediate-early lytic mRNA BZLF-1 transcripts, and by the presence of two early lytic transcripts (BALF-2, which appears to function in DNA replication, and BHRF-1, also associated with the replicative cycle). The late lytic BcLF-1 transcripts, which code for the major nucleocapsid protein, were also detected, as well as EBNA-1 transcripts. However, attempts to detect EBNA-2 transcripts have yielded negative results. Viral replication was also confirmed by the release of newly synthesized infectious viral particles in supernatants of EBV-infected monocytes. EBV-infected monocytes were found to have significantly reduced phagocytic activity, as evaluated by the quantification of ingested carboxylated fluoresceinated latex beads. Taken together, our results suggest that EBV infection of monocytes and alteration of their biological functions might represent a new mechanism to disrupt the immune response and promote viral propagation during the early stages of infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684275      PMCID: PMC111749          DOI: 10.1128/jvi.74.6.2612-2619.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage.

Authors:  M Shimakage; M Kimura; S Yanoma; M Ibe; S Yokota; G Tsujino; T Kozuka; T Dezawa; S Tamura; A Ohshima; M Yutsudo; A Hakura
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

2.  Signal transduction of phagocytosis.

Authors:  S Greenberg
Journal:  Trends Cell Biol       Date:  1995-03       Impact factor: 20.808

3.  Human immunodeficiency virus-1 env impairs Fc receptor-mediated phagocytosis via a cyclic adenosine monophosphate-dependent mechanism.

Authors:  C A Thomas; O K Weinberger; B L Ziegler; S Greenberg; I Schieren; S C Silverstein; J El Khoury
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

4.  Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.

Authors:  H Herbst; F Dallenbach; M Hummel; G Niedobitek; S Pileri; N Müller-Lantzsch; H Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Epstein-Barr virus modulates 5-lipoxygenase product synthesis in human peripheral blood mononuclear cells.

Authors:  J Gosselin; P Borgeat
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

6.  Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.

Authors:  K Takada; Y Ono
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

7.  An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene.

Authors:  T A Gahn; B Sugden
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

8.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

Authors:  B S Bender; B L Davidson; R Kline; C Brown; T C Quinn
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

10.  Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection.

Authors:  H Sprenger; R G Meyer; A Kaufmann; D Bussfeld; E Rischkowsky; D Gemsa
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  49 in total

Review 1.  Epstein-Barr virus entry.

Authors:  Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

2.  Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9.

Authors:  Ying Zheng; Zailong Qin; Qiurong Ye; Pan Chen; Zhen Wang; Qun Yan; Zhaohui Luo; Xiaoping Liu; Yanhong Zhou; Wei Xiong; Jian Ma; Guiyuan Li
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

3.  Macrophage involvement in Epstein-Barr virus-related tumors.

Authors:  Misuzu Shimakage; Haruhiko Sakamoto
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

4.  Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.

Authors:  Gregory K Hong; Pawan Kumar; Ling Wang; Blossom Damania; Margaret L Gulley; Henri-Jacques Delecluse; Peter J Polverini; Shannon C Kenney
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium.

Authors:  Sharof Tugizov; Rossana Herrera; Piri Veluppillai; John Greenspan; Deborah Greenspan; Joel M Palefsky
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.

Authors:  Shi-Dong Ma; Subramanya Hegde; Ken H Young; Ruth Sullivan; Deepika Rajesh; Ying Zhou; Ewa Jankowska-Gan; William J Burlingham; Xiaoping Sun; Margaret L Gulley; Weihua Tang; Jenny E Gumperz; Shannon C Kenney
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

7.  Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.

Authors:  Wangrong Wen; Dai Iwakiri; Koji Yamamoto; Seiji Maruo; Teru Kanda; Kenzo Takada
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes.

Authors:  François Michaud; François Coulombe; Eric Gaudreault; Carine Paquet-Bouchard; Marek Rola-Pleszczynski; Jean Gosselin
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

9.  Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophages in a rabbit model of Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  Wen-Chuan Hsieh; Yao Chang; Mei-Chi Hsu; Bau-Shin Lan; Guan-Chung Hsiao; Huai-Chia Chuang; Ih-Jen Su
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

10.  The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1.

Authors:  Yuling Li; Nupam P Mahajan; Jennifer Webster-Cyriaque; Prasanna Bhende; Gregory K Hong; H Shelton Earp; Shannon Kenney
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.